April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Apple: Dividend Growth Ahead, But a Near-Term Slide Likely
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Incyte (INCY) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: April 29, 2025 (20:57)
Sector: HealthcareThe share price of Incyte Corp. (INCY) now
Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2025, 2026, 2027. How much will one Incyte share be worth in 2025 - 2027?
When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock? We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.
Historical and forecast chart of Incyte stock
The chart below shows the historical price of Incyte stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.
Long-term forecasts by years.
Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.
Incyte daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 01 | 58.90 | 58.33 | 60.03 | 2.91 |
| May 02 | 58.70 | 57.50 | 59.44 | 3.37 |
| May 03 | 59.56 | 59.10 | 60.92 | 3.08 |
| May 04 | 59.78 | 59.10 | 61.14 | 3.46 |
| May 05 | 59.99 | 59.09 | 60.95 | 3.14 |
| May 06 | 59.42 | 58.19 | 60.04 | 3.19 |
| May 07 | 59.40 | 58.76 | 60.17 | 2.40 |
| May 08 | 59.40 | 58.62 | 60.20 | 2.71 |
| May 09 | 57.97 | 56.79 | 59.21 | 4.26 |
| May 10 | 58.32 | 57.76 | 58.85 | 1.88 |
| May 11 | 57.01 | 56.05 | 57.69 | 2.93 |
| May 12 | 58.53 | 58.04 | 59.32 | 2.21 |
| May 13 | 58.43 | 57.95 | 59.72 | 3.05 |
| May 14 | 60.18 | 59.51 | 61.35 | 3.09 |
| May 15 | 61.68 | 60.49 | 62.49 | 3.30 |
| May 16 | 62.47 | 62.02 | 63.45 | 2.30 |
| May 17 | 62.72 | 61.81 | 63.60 | 2.89 |
| May 18 | 64.34 | 63.87 | 65.71 | 2.87 |
| May 19 | 63.53 | 63.14 | 64.44 | 2.05 |
| May 20 | 63.28 | 61.83 | 63.79 | 3.16 |
| May 21 | 63.75 | 62.66 | 64.61 | 3.11 |
| May 22 | 63.01 | 61.63 | 64.20 | 4.17 |
| May 23 | 63.86 | 62.63 | 64.35 | 2.75 |
| May 24 | 64.62 | 63.21 | 65.40 | 3.47 |
| May 25 | 63.89 | 63.04 | 64.71 | 2.64 |
| May 26 | 63.18 | 62.31 | 64.18 | 3.01 |
| May 27 | 62.19 | 61.46 | 62.81 | 2.19 |
| May 28 | 60.72 | 60.15 | 61.77 | 2.69 |
| May 29 | 61.39 | 60.42 | 62.87 | 4.05 |
| May 30 | 59.70 | 58.57 | 60.86 | 3.91 |
Incyte Daily Price Targets
Incyte Stock Forecast 05-01-2025.
Forecast target price for 05-01-2025: $58.90.
Negative dynamics for Incyte shares will prevail with possible volatility of 2.826%.
Pessimistic target level: 58.33
Optimistic target level: 60.03
Incyte Stock Forecast 05-02-2025.
Forecast target price for 05-02-2025: $58.70.
Negative dynamics for Incyte shares will prevail with possible volatility of 3.259%.
Pessimistic target level: 57.50
Optimistic target level: 59.44
Incyte Stock Forecast 05-03-2025.
Forecast target price for 05-03-2025: $59.56.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.992%.
Pessimistic target level: 59.10
Optimistic target level: 60.92
Incyte Stock Forecast 05-04-2025.
Forecast target price for 05-04-2025: $59.78.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.344%.
Pessimistic target level: 59.10
Optimistic target level: 61.14
Incyte Stock Forecast 05-05-2025.
Forecast target price for 05-05-2025: $59.99.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.042%.
Pessimistic target level: 59.09
Optimistic target level: 60.95
Incyte Stock Forecast 05-06-2025.
Forecast target price for 05-06-2025: $59.42.
Negative dynamics for Incyte shares will prevail with possible volatility of 3.088%.
Pessimistic target level: 58.19
Optimistic target level: 60.04
INCY (INCY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 62.09 | 60.19 | 64.66 | 6.91 |
| Jun. | 61.75 | 60.20 | 65.75 | 8.45 |
| Jul. | 61.03 | 58.67 | 65.37 | 10.25 |
| Aug. | 60.32 | 57.28 | 61.62 | 7.05 |
| Sep. | 60.15 | 58.48 | 62.43 | 6.33 |
| Oct. | 57.56 | 55.48 | 61.39 | 9.62 |
| Nov. | 61.44 | 59.50 | 65.26 | 8.81 |
| Dec. | 63.21 | 59.17 | 65.09 | 9.09 |
Incyte forecast for this year
Incyte Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $62.0884. Pessimistic: $60.19. Optimistic: $64.66
Incyte Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $61.7531. Pessimistic: $60.20. Optimistic: $65.75
Incyte Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $61.0306. Pessimistic: $58.67. Optimistic: $65.37
Incyte Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $60.3166. Pessimistic: $57.28. Optimistic: $61.62
Incyte Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $60.1537. Pessimistic: $58.48. Optimistic: $62.43
Incyte Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $57.5551. Pessimistic: $55.48. Optimistic: $61.39
Incyte Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $61.44. Pessimistic: $59.50. Optimistic: $65.26
Incyte Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $63.2095. Pessimistic: $59.17. Optimistic: $65.09
Incyte (INCY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 61.90 | 60.23 | 64.24 | 6.24 |
| Feb | 65.80 | 63.02 | 67.76 | 6.99 |
| Mar | 62.90 | 60.86 | 64.88 | 6.19 |
| Apr | 61.37 | 58.22 | 63.86 | 8.82 |
| May | 65.62 | 62.43 | 68.40 | 8.72 |
| Jun | 65.74 | 63.32 | 69.88 | 9.40 |
| Jul | 67.34 | 64.31 | 69.64 | 7.66 |
| Aug | 68.31 | 65.17 | 69.72 | 6.52 |
| Sep | 74.40 | 71.78 | 75.94 | 5.47 |
| Oct | 72.99 | 68.59 | 77.13 | 11.07 |
| Nov | 73.71 | 71.06 | 75.37 | 5.72 |
| Dec | 69.40 | 66.40 | 73.46 | 9.61 |
Incyte (INCY) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 66.53 | 61.92 | 69.76 | 11.24 |
| Feb | 67.96 | 63.25 | 69.80 | 9.38 |
| Mar | 66.86 | 62.29 | 71.26 | 12.58 |
| Apr | 65.18 | 62.30 | 67.88 | 8.21 |
| May | 70.34 | 65.72 | 72.18 | 8.95 |
| Jun | 71.92 | 67.52 | 77.10 | 12.43 |
| Jul | 70.30 | 65.69 | 73.78 | 10.98 |
| Aug | 68.79 | 67.36 | 70.52 | 4.48 |
| Sep | 71.14 | 69.73 | 74.08 | 5.88 |
| Oct | 71.97 | 70.35 | 75.60 | 6.94 |
| Nov | 73.52 | 69.69 | 76.17 | 8.51 |
| Dec | 72.40 | 68.10 | 74.22 | 8.25 |
Incyte information and performance
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US
Market capitalization of the Incyte Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INCY shares in the company outstanding by the market price of one share.
EBITDA of Incyte is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Incyte Stock)
Should I Buy Incyte Shares in 2025 year?
Does Incyte pay dividends?
Which economic sector do Incyte's shares belong to?
Which other securities belong to the same sector as Incyte's shares?
